Skip to main content
Clinical Trials/NCT01398904
NCT01398904CompletedNot Applicable

Attentional Bias in Body Dysmorphic Disorder

Massachusetts General Hospital1 site in 1 country51 target enrollmentStarted: March 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
51
Locations
1
Primary Endpoint
Attention Pattern

Study Overview

Brief Summary

Body Dysmorphic Disorder (BDD) participants will demonstrate greater attentional biases as compared to healthy control (HC) participants. Greater attention bias will be associated with greater distress. Greater attention bias will be associated with greater symptom severity.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Major medical or neurological conditions
  • schizophrenia, schizoaffective disorder, or any other current lifetime DSM-IV psychotic disorder that is not attributable to delusional BDD
  • current suicidality
  • current homicidality
  • Exclusion criteria for healthy controls:
  • Any current Axis I psychiatric illness
  • history of BDD

Outcomes

Primary Outcomes

Attention Pattern

Time Frame: Day 2

Gaze tracking via an Eyelink II eye tracker will determine perception of visual information.

Secondary Outcomes

  • Facial Attractiveness(Day 2)
  • Subjective Units of Distress Scale (SUDS)(Day 2)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sabine Wilhelm

Director, OCD & Related Disorders Program

Massachusetts General Hospital

Study Sites (1)

Loading locations...

Similar Trials